(10-431) Outcomes from Weight-based Intravenous Heparin Dosing in Morbid Obesity for Acute Coronary Syndromes, Atrial Fibrillation, Atrial Flutter, and Peripheral Artery Disease

Wednesday, December 7, 2022

11:00 AM – 12:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Cardiology/Anticoagulation

Co-Author(s): Carrie Molesa

Primary Author(s)

Allison N. Spitery, PharmD
PGY1 Pharmacy Resident
Detroit Medical Center, Harper-Hutzel Hospital, Michigan